ProfileGDS4718 / 213834_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 43% 52% 51% 49% 48% 40% 41% 51% 47% 51% 42% 50% 51% 42% 45% 49% 45% 42% 45% 51% 55% 49% 49% 46% 47% 42% 48% 46% 48% 52% 47% 47% 50% 50% 61% 47% 50% 45% 49% 49% 50% 49% 46% 43% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1297743
GSM549102patient 115, normal, homogenized [OPG study]5.6319452
GSM549104patient 119, normal, homogenized [OPG study]5.5706351
GSM549108patient 138, normal, homogenized [OPG study]5.4940449
GSM549119patient 077, normal, homogenized [OPG study]5.3893148
GSM549133patient 032, cancer, homogenized [OPG study]4.9280140
GSM549139patient 042, cancer, homogenized [OPG study]5.0406541
GSM549099patient 107, normal, homogenized [OPG study]5.5921151
GSM549109patient 139, normal, homogenized [OPG study]5.3849947
GSM549110patient 046, normal, homogenized [OPG study]5.5601451
GSM549114patient 063, normal, homogenized [OPG study]5.0598242
GSM549122patient 082, normal, homogenized [OPG study]5.5257250
GSM549134patient 033, cancer, homogenized [OPG study]5.528351
GSM549136patient 036, cancer, homogenized [OPG study]5.0041842
GSM549140patient 044, cancer, homogenized [OPG study]5.2057645
GSM549111patient 047, normal, homogenized [OPG study]5.4196549
GSM549113patient 057, normal, homogenized [OPG study]5.2072945
GSM549132patient 031, cancer, homogenized [OPG study]5.0591242
GSM549137patient 038, cancer, homogenized [OPG study]5.1940945
GSM549142patient 047, cancer, homogenized [OPG study]5.7122751
GSM549100patient 110, normal, homogenized [OPG study]5.7952855
GSM549107patient 135, normal, homogenized [OPG study]5.4179249
GSM549115patient 068, normal, homogenized [OPG study]5.3982449
GSM549116patient 072, normal, homogenized [OPG study]5.2899746
GSM549120patient 078, normal, homogenized [OPG study]5.3339547
GSM549131patient 030, cancer, homogenized [OPG study]5.0210142
GSM549118patient 074, normal, homogenized [OPG study]5.4048448
GSM549129patient 027, cancer, homogenized [OPG study]5.2995546
GSM549123patient 088, normal, homogenized [OPG study]5.3653648
GSM549124patient 006, cancer, homogenized [OPG study]5.6406652
GSM549126patient 015, cancer, homogenized [OPG study]5.3472347
GSM549128patient 025, cancer, homogenized [OPG study]5.3232847
GSM549103patient 117, normal, homogenized [OPG study]5.5661650
GSM549117patient 073, normal, homogenized [OPG study]5.4648150
GSM549138patient 041, cancer, homogenized [OPG study]6.2031561
GSM549141patient 045, cancer, homogenized [OPG study]5.2743747
GSM549130patient 028, cancer, homogenized [OPG study]5.4879750
GSM549101patient 111, normal, homogenized [OPG study]5.2753445
GSM549105patient 128, normal, homogenized [OPG study]5.482949
GSM549106patient 134, normal, homogenized [OPG study]5.4258249
GSM549112patient 048, normal, homogenized [OPG study]5.5006350
GSM549125patient 011, cancer, homogenized [OPG study]5.4795349
GSM549127patient 024, cancer, homogenized [OPG study]5.2871146
GSM549135patient 035, cancer, homogenized [OPG study]5.1165843